How does pindolol improve antidepressant action?

Trends in Pharmacological Sciences
F ArtigasA Adell

Abstract

Since 1994, the beta-adrenoceptor and 5-HT(1A/1B) receptor ligand pindolol has been used to accelerate or enhance the clinical effects of antidepressant drugs, such as the selective 5-HT reuptake inhibitors (SSRIs), that act primarily on 5-HT-containing neurones. Pindolol was initially thought to act by preventing the inhibition of 5-HT release, elicited by SSRIs and other 5-HT-acting drugs, as a result of its ability to antagonize the action of 5-HT at midbrain raphe 5-HT(1A) autoreceptors that control the activity of ascending 5-HT-mediated pathways. However, the partial agonist properties of pindolol at 5-HT(1A) receptors and beta-adrenoceptors suggest that other explanations for its action are also possible. In this article, recent controversial data on the mechanism of action of pindolol, which are crucial for the development of more rapid and efficient antidepressant therapies, will be discussed.

References

Jan 1, 1991·Journal of Receptor Research·D Hoyer, P Schoeffter
Nov 1, 1990·Archives of Internal Medicine·B Q ThiessenU Bergman
Jun 1, 1990·Neurochemical Research·C WaeberJ M Palacios
May 1, 1988·Journal of Neurochemistry·K Herrick-Davis, M Titeler
Jul 1, 1994·Trends in Pharmacological Sciences·P Blier, C de Montigny
Jul 1, 1993·Trends in Pharmacological Sciences·F Artigas
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·N AdhamT A Branchek
Apr 1, 1993·Pharmacology, Biochemistry, and Behavior·J C Winter, R A Rabin
Dec 31, 1997·The Journal of Clinical Psychiatry·F A MorenoP L Delgado
Dec 31, 1997·Journal of Clinical Psychopharmacology·R ZanardiJ Perez
Apr 16, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Newman-TancrediM J Millan
Mar 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E SmeraldiC Colombo
Oct 16, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Isaac
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E A RabinerP M Grasby
Feb 13, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D MartinezM Laruelle
Aug 28, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·V AudinotM J Millan

❮ Previous
Next ❯

Citations

Jan 2, 2003·Annals of Nuclear Medicine·W Gordon Frankle, Marc Laruelle
Nov 26, 2010·Psychopharmacology·Gregory V Carr, Irwin Lucki
Mar 27, 2004·European Journal of Pharmacology·Marco Giorgetti, Laurence H Tecott
May 27, 2005·Life Sciences·Eduarda FernandesJosé L F C Lima
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Eliyahu DremencovGal Yadid
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Brian J Jones, Thomas P Blackburn
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Daniel HoyerGraeme R Martin
Nov 8, 2001·Trends in Pharmacological Sciences·F Chaouloff
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter S Talbot, Marc Laruelle
Jan 22, 2013·ACS Chemical Neuroscience·Francesc Artigas
Oct 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Zaorui ZhaoJames M O'Donnell
Jul 14, 2011·Neuropsychiatric Disease and Treatment·Chantal Moret, Mike Briley
Jun 24, 2008·Neuropsychiatric Disease and Treatment·Francis E Lotrich, Bruce G Pollock
Aug 12, 2015·International Journal of Molecular Sciences·Zdzisław ChilmonczykIngebrigt Sylte
Jul 22, 2008·Neuropharmacology·Brice Le FrançoisPaul R Albert
Sep 7, 2007·Bioorganic & Medicinal Chemistry Letters·Joseph H KrushinskiDavid T Wong
Nov 15, 2006·Neuropharmacology·Nicolas Aznavour, Luc Zimmer
Jan 30, 2004·Fundamental & Clinical Pharmacology·D A SlatteryD J Nutt
Nov 3, 2004·The American Journal of Cardiology·Nandini NairBharat K Kantharia
Mar 31, 2006·European Journal of Pharmacology·Claire ScottJeannette Watson
Sep 15, 2005·Neuroscience and Biobehavioral Reviews·Julie G Hensler
Jul 16, 2005·Biological Psychiatry·Peter B HedlundJ Gregor Sutcliffe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.